JP2020513844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020513844A5 JP2020513844A5 JP2019565052A JP2019565052A JP2020513844A5 JP 2020513844 A5 JP2020513844 A5 JP 2020513844A5 JP 2019565052 A JP2019565052 A JP 2019565052A JP 2019565052 A JP2019565052 A JP 2019565052A JP 2020513844 A5 JP2020513844 A5 JP 2020513844A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- vitro
- cell precursors
- population
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022154550A JP2022185024A (ja) | 2017-02-13 | 2022-09-28 | Ｔ細胞前駆体を産生させるための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305161 | 2017-02-13 | ||
| EP17305161.6 | 2017-02-13 | ||
| PCT/EP2018/053406 WO2018146297A1 (en) | 2017-02-13 | 2018-02-12 | Method for generating t cells progenitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022154550A Division JP2022185024A (ja) | 2017-02-13 | 2022-09-28 | Ｔ細胞前駆体を産生させるための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020513844A JP2020513844A (ja) | 2020-05-21 |
| JP2020513844A5 true JP2020513844A5 (enExample) | 2021-03-25 |
| JP7164798B2 JP7164798B2 (ja) | 2022-11-02 |
Family
ID=58185453
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565052A Active JP7164798B2 (ja) | 2017-02-13 | 2018-02-12 | Ｔ細胞前駆体を産生させるための方法 |
| JP2022154550A Pending JP2022185024A (ja) | 2017-02-13 | 2022-09-28 | Ｔ細胞前駆体を産生させるための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022154550A Pending JP2022185024A (ja) | 2017-02-13 | 2022-09-28 | Ｔ細胞前駆体を産生させるための方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US20200046767A1 (enExample) |
| EP (2) | EP3580330B1 (enExample) |
| JP (2) | JP7164798B2 (enExample) |
| KR (1) | KR102666158B1 (enExample) |
| CN (1) | CN110506110B (enExample) |
| AU (1) | AU2018217404B2 (enExample) |
| BR (1) | BR112019016672A8 (enExample) |
| CA (1) | CA3053294A1 (enExample) |
| DK (1) | DK3580330T3 (enExample) |
| ES (1) | ES2931530T3 (enExample) |
| HU (1) | HUE060548T2 (enExample) |
| IL (1) | IL268641B2 (enExample) |
| MA (1) | MA47541A (enExample) |
| PL (1) | PL3580330T3 (enExample) |
| PT (1) | PT3580330T (enExample) |
| WO (1) | WO2018146297A1 (enExample) |
| ZA (1) | ZA201905470B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2931530T3 (es) * | 2017-02-13 | 2022-12-30 | Hopitaux Paris Assist Publique | Método para generar progenitores de células T |
| CA3077344A1 (en) * | 2017-09-29 | 2019-04-04 | Regents Of The University Of Minnesota | Methods of making, expanding, and using a human progenitor t cell |
| EP3700334B1 (en) | 2017-10-27 | 2026-04-08 | Immunebridge Inc. | Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene |
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
| EP3847243A1 (en) * | 2018-09-07 | 2021-07-14 | Wisconsin Alumni Research Foundation | Generation of hematopoietic progenitor cells from human pluripotent stem cells |
| WO2020223517A1 (en) * | 2019-05-01 | 2020-11-05 | Transfusion Health, Llc | Methods of making oligopotent and unipotent precursors |
| CA3144640A1 (en) * | 2019-06-24 | 2020-12-30 | Children's Hospital Los Angeles | Bcl11b overexpression to enhance human thymopoiesis and t cell function |
| EP4058562A4 (en) * | 2019-11-14 | 2023-12-20 | Zandstra, Peter William | MEDIA FORMULATIONS AND PROCESSES FOR PRODUCING PROGENITOR T CELLS |
| WO2021200901A1 (ja) * | 2020-03-31 | 2021-10-07 | 国立大学法人京都大学 | Ｔ前駆細胞の製造方法 |
| CN116615461A (zh) | 2020-11-30 | 2023-08-18 | 醣基生医股份有限公司 | 用于富集细胞的抗体 |
| CA3209946A1 (en) * | 2021-03-05 | 2022-09-09 | Matthew Angel | Engineered immune cell therapies |
| EP4347793A1 (en) * | 2021-05-25 | 2024-04-10 | Universiteit Gent | Generating t cell precursors via agonizing tumor necrosis factor receptor 2 |
| US20260152721A1 (en) | 2021-11-04 | 2026-06-04 | Aphp (Assistance Publique - Hôpitaux De Paris) | Method for generating nk cells |
| FR3130843A1 (fr) * | 2021-12-21 | 2023-06-23 | Universite Claude Bernard Lyon 1 | Cellule progéniteur des lymphocytes T exprimant de manière régulée un transgène d’intérêt |
| KR20250150555A (ko) | 2023-01-27 | 2025-10-20 | 노치 테라퓨틱스 (캐나다) 인크. | 줄기세포/전구세포로부터 t 세포 계통 모집단을 생성하는 방법 |
| KR20250152088A (ko) * | 2023-02-22 | 2025-10-22 | 메이라지티엑스 셀 테라피스 | 흉선 재생 방법 |
| US20250332260A1 (en) | 2024-04-10 | 2025-10-30 | Garuda Therapeutics, Inc. | Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations |
| WO2025219552A1 (en) | 2024-04-17 | 2025-10-23 | Assitance Publique Hopitaux De Paris | Method for producing t cell progenitors from human pluripotent stem cells |
| CN121969764A (zh) * | 2024-08-29 | 2026-05-01 | 京东方科技集团股份有限公司 | 引物设计、疾病分型诊断方法及装置、组合物、试剂盒及其用途 |
| CN119709836B (zh) * | 2024-12-21 | 2025-08-08 | 湖南农业大学 | OsProT2基因在调控水稻镉含量、镉耐受性及产量中的应用和方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
| WO1999028486A1 (en) | 1997-12-04 | 1999-06-10 | Duke University | Methods of isolating and using cd7+cd34-lin-hematopoietic cells |
| US10059923B2 (en) | 2008-01-30 | 2018-08-28 | Memorial Sloan Kettering Cancer Center | Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors |
| CA2737193A1 (en) | 2008-09-12 | 2010-03-18 | Universidade Federal De Sao Paulo - Unifesp | Ischemic tissue cell therapy |
| US8772028B2 (en) * | 2008-11-07 | 2014-07-08 | Sunnybrook Health Sciences Centre | CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using |
| US8871510B2 (en) | 2009-12-03 | 2014-10-28 | University Of Utah Research Foundation | Methods for generating T lymphocytes from hematopoietic stem cells |
| EP3590520B1 (en) | 2010-04-09 | 2021-12-29 | Fred Hutchinson Cancer Research Center | Compositions for providing hematopoietic function without hla matching |
| WO2013074916A1 (en) | 2011-11-18 | 2013-05-23 | Board Of Regents, The University Of Texas System | Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla |
| WO2013086436A1 (en) * | 2011-12-08 | 2013-06-13 | Fred Hutchinson Cancer Research Center | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
| US20150352180A1 (en) | 2013-01-11 | 2015-12-10 | The Trustee Of The University Of Pennsylvania | Notch Ligand Bound Biocompatible Substrates And Their Use In Bone Formation |
| EP3027755B1 (en) * | 2013-08-02 | 2019-10-09 | The Regents of The University of California | Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors |
| US20170128556A1 (en) | 2013-12-26 | 2017-05-11 | Thyas Co. Ltd. | Immunotherapy using t precursor cells derived from pluripotent stem cells having rearranged t cell receptor genes |
| US20170158749A1 (en) | 2014-04-23 | 2017-06-08 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) and methods for making and using the same |
| JP6661544B2 (ja) * | 2014-04-24 | 2020-03-11 | ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング | 遺伝子改変したｔ細胞の自動生成法 |
| WO2016039933A1 (en) | 2014-09-11 | 2016-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lentiviral vector for treating hemoglobin disorders |
| FR3026744B1 (fr) * | 2014-10-06 | 2024-04-19 | Hopitaux Paris Assist Publique | Methode de generation de progeniteurs de cellules t |
| US11555207B2 (en) * | 2015-06-17 | 2023-01-17 | The Uab Research Foundation | CRISPR/Cas9 complex for introducing a functional polypeptide into cells of blood cell lineage |
| US12076342B2 (en) | 2016-04-08 | 2024-09-03 | The Governing Council Of The University Of Toronto | Method for generating progenitor t cells from stem and/or progenitor cells and use of same |
| ES2931530T3 (es) * | 2017-02-13 | 2022-12-30 | Hopitaux Paris Assist Publique | Método para generar progenitores de células T |
-
2018
- 2018-02-12 ES ES18704551T patent/ES2931530T3/es active Active
- 2018-02-12 EP EP18704551.3A patent/EP3580330B1/en active Active
- 2018-02-12 IL IL268641A patent/IL268641B2/en unknown
- 2018-02-12 CN CN201880024963.1A patent/CN110506110B/zh active Active
- 2018-02-12 EP EP22158116.8A patent/EP4067482A1/en active Pending
- 2018-02-12 US US16/485,488 patent/US20200046767A1/en not_active Abandoned
- 2018-02-12 MA MA047541A patent/MA47541A/fr unknown
- 2018-02-12 HU HUE18704551A patent/HUE060548T2/hu unknown
- 2018-02-12 BR BR112019016672A patent/BR112019016672A8/pt unknown
- 2018-02-12 PT PT187045513T patent/PT3580330T/pt unknown
- 2018-02-12 PL PL18704551.3T patent/PL3580330T3/pl unknown
- 2018-02-12 WO PCT/EP2018/053406 patent/WO2018146297A1/en not_active Ceased
- 2018-02-12 CA CA3053294A patent/CA3053294A1/en active Pending
- 2018-02-12 DK DK18704551.3T patent/DK3580330T3/da active
- 2018-02-12 AU AU2018217404A patent/AU2018217404B2/en active Active
- 2018-02-12 KR KR1020197024529A patent/KR102666158B1/ko active Active
- 2018-02-12 JP JP2019565052A patent/JP7164798B2/ja active Active
-
2019
- 2019-08-19 ZA ZA2019/05470A patent/ZA201905470B/en unknown
-
2020
- 2020-09-02 US US17/010,208 patent/US11426430B2/en active Active
-
2021
- 2021-02-11 US US17/173,668 patent/US11642376B2/en active Active
- 2021-02-11 US US17/173,632 patent/US11638723B2/en active Active
-
2022
- 2022-09-28 JP JP2022154550A patent/JP2022185024A/ja active Pending
-
2023
- 2023-04-06 US US18/296,623 patent/US20230293586A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11642376B2 (en) | Method for generating T cell progenitors | |
| ES2824767T3 (es) | Anticuerpos anti-CD4 modificados | |
| JP5450395B2 (ja) | Ｒｓｖ特異的結合分子およびその製造方法 | |
| AU2018388079B2 (en) | Immunocompetent cell that expresses a cell surface molecule specifically recognizing human mesothelin, IL-7 and CCL19 | |
| JP2021536237A5 (enExample) | ||
| US20180208895A1 (en) | Method for generating t-cell progenitors | |
| CN116693691A (zh) | 在治疗HvG病中使用的融合蛋白 | |
| JP2021534815A5 (enExample) | ||
| JP2022511735A5 (enExample) | ||
| JP2022526372A (ja) | ＨｖＧ疾患の処置における使用のためのＣＡＲ | |
| JP2017531448A5 (enExample) | ||
| JPWO2012096376A1 (ja) | 制御性ｔ細胞の製造方法 | |
| US20170137782A1 (en) | Method for producing b cell population | |
| JP7439280B2 (ja) | キメラ抗原受容体の最適化 | |
| US7455962B1 (en) | Method for preparing cell fraction containing hemangioblasts | |
| JP2004519437A (ja) | 移植寛容を増進させ、損傷組織を治療する為の胚性幹細胞由来細胞の利用 | |
| WO2005045026A1 (ja) | 可逆的に増殖可能なインスリン発現ヒト膵島細胞株およびその用途 | |
| JP5720980B2 (ja) | クッパー細胞の効率的増殖方法およびその利用 | |
| JP5466326B1 (ja) | ラットモノクローナル抗体作製用パートナー細胞およびそのスクリーニング方法 | |
| WO2026071075A1 (ja) | 幹細胞由来肝細胞、当該幹細胞由来肝細胞を含む肝移植用組成物、凍結耐性を有する多能性幹細胞由来肝細胞の製造方法、凍結耐性を有する肝細胞を選別するための分子マーカーの使用、ならびに肝前駆細胞または肝細胞の純化方法 | |
| HK40081656A (en) | Method for generating t cells progenitors | |
| HK40017982B (en) | Method for generating t cells progenitors | |
| HK40017982A (en) | Method for generating t cells progenitors |